CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science of China (81202433, 21132009)
  • National Major Scientific and Technological Special project for “Significant New Drugs Development” during the Twelfth Five-year Plan Period (2012ZX09301002-006)

This publication has 50 references indexed in Scilit: